Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

non-small-cell lung cancer

  • You have access
    Serum Inflammatory Dynamics as Novel Biomarkers for Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer With Bone Metastases
    YOHEI ASANO, NORIO YAMAMOTO, KATSUHIRO HAYASHI, AKIHIKO TAKEUCHI, SATOSHI KATO, SHINJI MIWA, MIHO OKUDA, ISAO MATSUMOTO, SEIJI YANO and SATORU DEMURA
    Anticancer Research October 2024, 44 (10) 4493-4503; DOI: https://doi.org/10.21873/anticanres.17278
  • You have access
    Safety and Efficacy of Durvalumab After Chemoradiotherapy in Antinuclear Antibody-positive Patients With Non-small Cell Lung Cancer
    AKIHIRO TSUKAGUCHI, AKIHIRO TAMIYA, SHOICHI FUKUDA, YUKI IWAHASHI, KENSUKE KANAOKA, YUYA TANAKA, YUJI INAGAKI, YOSHIHIKO TANIGUCHI, KEIKO NAKAO, TOMOKO KAGAWA, YOSHINOBU MATSUDA and KYOICHI OKISHIO
    Anticancer Research October 2024, 44 (10) 4517-4524; DOI: https://doi.org/10.21873/anticanres.17280
  • You have access
    Clinical Significance of Nodal DCsign Expression in Non-small-cell Lung Cancer Patients
    MASAYA AOKI, GO KAMIMURA, SHOICHIRO MORIZONO, TAKUYA TOKUNAGA, TADASHI UMEHARA, AYA HARADA-TAKEDA, KOKI MAEDA, TOSHIYUKI NAGATA, KAZUHIRO UEDA, KAZUHIRO TABATA, GEN MURAKAMI and MASAMI SATO
    Anticancer Research July 2023, 43 (7) 3003-3013; DOI: https://doi.org/10.21873/anticanres.16471
  • Open Access
    Possible False Results With cobas® EGFR Mutation Test v2 and Oncomine Dx Target Test for EGFR Mutation
    KENSUKE KANAOKA, AKIHIRO TAMIYA, YUJI INAGAKI, YOSHIHIKO TANIGUCHI, KEIKO NAKAO, MAIKO TAKEDA, YOSHINOBU MATSUDA, KYOICHI OKISHIO and SHIGEKI SHIMIZU
    Anticancer Research June 2023, 43 (6) 2771-2776; DOI: https://doi.org/10.21873/anticanres.16445
  • You have access
    Clinical Outcomes Beyond 1L EGFR-TKI Progression in mNSCLC: Final Results of the Real-World Study ‘LUNGFUL’
    GIANNIS MOUNTZIOS, ANNA KOUMARIANOU, HELENA LINARDOU, ANASTASIOS BOUTIS, DIMITRIOS MAVROUDIS, EPAMINONDAS SAMANTAS, IPPOKRATIS KORANTZIS, ELIAS ATHANASIADIS, EVANGELOS G. FERGADIS, SOFIA LAMPAKI, VASSILIS GEORGOULIAS, SOFIA BAKA, MICHALIS V. KARAMOUZIS, IOANNIS BOUKOVINAS, CHARALAMPOS ANDREADIS, AGGELIKI RAPTI, NIKOLAOS KOULOURIS, GEORGE PENTHEROUDAKIS, MARIOS E. FROUDARAKIS, ALVERTOS SOMARAKIS, ELEFTHERIA ANASTASOPOULOU, ALEXANDRA KARADIMOU, FOTEINI PAPAGEORGIOU, ZOE PAPAREPA, ARISTEIDIS NIKOLAOU, CHRISTINA PAPISTA and KONSTANTINOS N. SYRIGOS
    Anticancer Research May 2023, 43 (5) 2243-2258; DOI: https://doi.org/10.21873/anticanres.16388
  • You have access
    Effect of Interstitial Lung Abnormality on Concurrent Chemoradiotherapy-treated Stage III Non-small Cell Lung Cancer Patients
    WON GI JEONG, YUN-HYEON KIM, SUNG-JA AHN, JAE-UK JEONG, BYUNG CHAN LEE, ICK JOON CHO and YONG-HYUB KIM
    Anticancer Research April 2023, 43 (4) 1797-1807; DOI: https://doi.org/10.21873/anticanres.16333
  • You have access
    Discontinuation of Immune Checkpoint Inhibitor and Survival in Patients With Non-small-cell Lung Cancer Without a Driver Gene Mutation
    SOU HATTORI, SHINICHIRO OKAUCHI, YUIKA SASATANI, GEN OHARA, KUNIHIKO MIYAZAKI, SHINYA SATO, TAKAHIDE KODAMA, TOSHIHIRO SHIOZAWA, HIROAKI SATOH and NOBUYUKI HIZAWA
    Anticancer Research September 2022, 42 (9) 4589-4595; DOI: https://doi.org/10.21873/anticanres.15962
  • You have access
    Magnolol Induces Apoptosis Through Extrinsic/intrinsic Pathways and Attenuates NF-κB/STAT3 Signaling in Non-small-cell Lung Cancer Cells
    YANG-CHENG LEE, YUEH-SHAN WENG, HSIAO-YU WANG, FEI-TING HSU, FU-SHIN CHUEH, JENG-YUAN WU, WEI-LUNG CHEN and JIANN-HWA CHEN
    Anticancer Research August 2022, 42 (8) 3825-3833; DOI: https://doi.org/10.21873/anticanres.15873
  • You have access
    Knockdown of NUPR1 Enhances the Sensitivity of Non-small-cell Lung Cancer Cells to Metformin by AKT Inhibition
    YU JIN KIM, SUNG-EUN HONG, SE-KYEONG JANG, KI SOO PARK, CHUN-HO KIM, IN-CHUL PARK and HYEON-OK JIN
    Anticancer Research July 2022, 42 (7) 3475-3481; DOI: https://doi.org/10.21873/anticanres.15834
  • You have access
    A Novel Molecular Target in EGFR-mutant Lung Cancer Treated With the Combination of Osimertinib and Pemetrexed
    NATSUKI TAKANO, MASAHIRO SEIKE, TEPPEI SUGANO, KUNIKO MATSUDA, KAKERU HISAKANE, AKIKO YOSHIKAWA, SHINJI NAKAMICHI, RINTARO NORO and AKIHIKO GEMMA
    Anticancer Research February 2022, 42 (2) 709-722; DOI: https://doi.org/10.21873/anticanres.15529

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire